 | Geraldine Henwood*
Ms. Henwood has been a director of Alkermes since April 2003. She is the CEO and President of Recro Pharma Inc., the interim CEO and Director of Garnet BioTherapeutics, Inc., and a consultant with Malvern Consulting Group and SCP Partners. She was the co-founder and Chief Executive Officer of Auxilium Pharmaceuticals, Inc. Prior to founding Auxilium, Ms. Henwood founded, in 1985, a contract research organization (CRO), IBAH, Inc. Prior to founding IBAH, Ms. Henwood was employed by SmithKline Beecham in various capacities including senior medical and regulatory positions. Ms. Henwood is a member of the Board of Directors of LZ Therapeutics. She is also a trustee of LaSalle Academy. |
Print Page 
Email Page 
RSS 
Email Alerts 
Tear Sheet
